Oral Cancer :: USC School of Dentistry researchers discover link between oral cancer and ethnicity

Clinicians from the USC School of Dentistry unravel connection between the incidence of oral cancer and race and ethnicity– as part of first epidemiological study of oral cancer in California. Dr. Satish Kumar and Dr.Parish Sedghizadeh, clinical professors in the school’s Division of Diagnostic Sciences, gleaned through 20 years of records from the California Cancer Registry (CCR)—the state’s cancer surveillance database—for the incidence rates of invasive squamous cell carcinoma, the most common form of oral cancer.

Hepatitis B :: Decrease in Liver Transplant in Patients with Hepatitis B

A new Mayo Clinic study found a nationwide decrease in the need for liver transplant in patients with hepatitis B, which coincides with the increasingly widespread use of oral antiviral medications to slow disease progression. The study will be presented this week at the annual meeting of the American Association for the Study of Liver Diseases in Boston.

Rheumatoid Arthritis :: Cardiovascular Disease Risk for Rheumatoid Arthritis Patients

People with rheumatoid arthritis have a higher risk for developing heart disease than the general population; however, it is difficult to identify which patients are at increased risk. Researchers at Mayo Clinic have developed a simple approach to predict heart disease in these patients within ten years of their initial diagnosis of rheumatoid arthritis.

Lupus :: Immunosuppressive drug effective for reducing lupus flares

Mayo Clinic researchers have shown that an immunosuppressive drug used in organ transplant cases is effective in reducing flare-ups in patients with systemic lupus erythematosus (SLE). SLE results in inflammation of connective tissues and can involve the skin, joints and kidneys. Its cause is unknown. The findings were announced today at the annual meeting of the American College of Rheumatology in Boston.

Ovarian Cancer :: New Therapy for Patients with Platinum-Resistant Ovarian Cancer

Mayo Clinic reported promising interim results from a Phase II trial of a new combination therapy for patients with recurrent ovarian cancer that is resistant to platinum therapy. Thirty-three percent of study participants achieved either complete or partial tumor regression from the therapy, which combines flavopiridol and cisplatin.

Multiple Sclerosis :: Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease

An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis (MS). Neurology researchers led by Abdolmohamad Rostami, M.D., Ph.D., professor and chair of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University and the Jefferson Hospital for Neuroscience in Philadelphia, have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease.

Psychology :: Men are significantly more talkative than women

It’s a research that is likely to leave men speechless — males, not females, are chatterboxes. International researchers have carried out a study and found that men out-talk women, dispelling the long-held myth that females cannot stop chattering.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack